Search Results

There are 10406 results for: content related to: Olanzapine in the prevention of postpartum psychosis and mood episodes in bipolar disorder

  1. You have full text access to this OnlineOpen article
    The Influence of Drug Physical State on the Dissolution Enhancement of Solid Dispersions Prepared Via Hot-Melt Extrusion: A Case Study Using Olanzapine

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 4, April 2014, Pages: 1214–1223, Maria Fátima Pina, Min Zhao, João F. Pinto, João J. Sousa and Duncan Q. M. Craig

    Version of Record online : 7 FEB 2014, DOI: 10.1002/jps.23894

  2. Olanzapine plus fluoxetine treatment alters mitochondrial respiratory chain activity in the rat brain

    Acta Neuropsychiatrica

    Volume 23, Issue 6, December 2011, Pages: 282–291, Fabiano R. Agostinho, Gislaine Z. Réus, Roberto B. Stringari, Karine F. Ribeiro, Gabriela K. Ferreira, Isabela C. Jeremias, Giselli Scaini, Gislaine T. Rezin, Emílio L. Streck and João Quevedo

    Version of Record online : 30 JUN 2011, DOI: 10.1111/j.1601-5215.2011.00569.x

  3. You have free access to this content
    Profiling of Energy Metabolism in Olanzapine-Induced Weight Gain in Rats and Its Prevention by the CB1-Antagonist AVE1625

    Obesity

    Volume 18, Issue 10, October 2010, Pages: 1952–1958, Michaela Liebig, Matthias Gossel, Jeremy Pratt, Mark Black, Guido Haschke, Ralf Elvert, Hans-Paul Juretschke, Claudia Neumann-Haefelin, Werner Kramer and Andreas W. Herling

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2010.17

  4. Evaluating the performance of different procedures for constructing confidence intervals for coefficient alpha: A simulation study

    British Journal of Mathematical and Statistical Psychology

    Volume 65, Issue 3, November 2012, Pages: 467–498, Ying Cui and Johnson Li

    Version of Record online : 1 FEB 2012, DOI: 10.1111/j.2044-8317.2012.02038.x

  5. You have free access to this content
    Indirect comparison analysis of efficacy and safety between olanzapine and aripiprazole for schizophrenia

    British Journal of Clinical Pharmacology

    Volume 77, Issue 5, May 2014, Pages: 767–776, Taro Kunitomi, Masayuki Hashiguchi and Mayumi Mochizuki

    Version of Record online : 22 APR 2014, DOI: 10.1111/bcp.12221

  6. You have free access to this content
    Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E2 concentration in rat brain

    Journal of Neurochemistry

    Volume 119, Issue 2, October 2011, Pages: 364–376, Yewon Cheon, Jee-Young Park, Hiren R. Modi, Hyung-Wook Kim, Ho-Joo Lee, Lisa Chang, Jagadeesh S. Rao and Stanley I. Rapoport

    Version of Record online : 20 SEP 2011, DOI: 10.1111/j.1471-4159.2011.07410.x

  7. You have free access to this content
    Cost-Effectiveness of Olanzapine as First-Line Treatment for Schizophrenia: Results from a Randomized, Open-Label, 1-Year Trial

    Value in Health

    Volume 9, Issue 2, March 2006, Pages: 77–89, Sandra L. Tunis, Douglas E. Faries, Allen W. Nyhuis, Bruce J. Kinon, Haya Ascher-Svanum and Ralph Aquila

    Version of Record online : 19 DEC 2005, DOI: 10.1111/j.1524-4733.2006.00083.x

  8. Criterion-Related Validity of Challenging Behaviour Scales: A Review of Evidence in the Literature

    Journal of Applied Research in Intellectual Disabilities

    Volume 28, Issue 2, March 2015, Pages: 81–97, Raistrick W. Turton

    Version of Record online : 15 MAY 2014, DOI: 10.1111/jar.12098

  9. You have free access to this content
    Increased Food Intake and Energy Expenditure Following Administration of Olanzapine to Healthy Men

    Obesity

    Volume 18, Issue 8, August 2010, Pages: 1646–1651, Robert J. Fountaine, Ann E. Taylor, James P. Mancuso, Frank L. Greenway, Lauri O. Byerley, Steven R. Smith, Marlene M. Most and David A. Fryburg

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2010.6

  10. Diagnostic guidelines for bipolar depression: a probabilistic approach

    Bipolar Disorders

    Volume 10, Issue 1p2, February 2008, Pages: 144–152, Philip B Mitchell, Guy M Goodwin, Gordon F Johnson and Robert MA Hirschfeld

    Version of Record online : 10 JAN 2008, DOI: 10.1111/j.1399-5618.2007.00559.x

  11. You have free access to this content
    Pharmacokinetics and tolerability of lamotrigine and olanzapine coadministered to healthy subjects

    British Journal of Clinical Pharmacology

    Volume 61, Issue 4, April 2006, Pages: 420–426, Jagdev Sidhu, Sarah Job, Jonathan Bullman, Emma Francis, Richard Abbott, John Ascher and Jochen G. W. Theis

    Version of Record online : 24 JAN 2006, DOI: 10.1111/j.1365-2125.2006.02598.x

  12. Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease

    International Journal of Geriatric Psychiatry

    Volume 19, Issue 2, February 2004, Pages: 115–126, Peter Paul De Deyn, Manuel Martín Carrasco, Walter Deberdt, Claude Jeandel, Donald P. Hay, Peter D. Feldman, Carrie A. Young, Deborah L. Lehman and Alan Breier

    Version of Record online : 28 JAN 2004, DOI: 10.1002/gps.1032

  13. Olanzapine vs haloperidol in geriatric schizophrenia: analysis of data from a double-blind controlled trial

    International Journal of Geriatric Psychiatry

    Volume 18, Issue 11, November 2003, Pages: 1013–1020, J. S. Kennedy, D. Jeste, C. J. Kaiser, S. Golshan, G. A. Maguire, G. Tollefson, T. Sanger, F. P. Bymaster, B. J. Kinon, M. Dossenbach, J. A. Gilmore and A. Breier

    Version of Record online : 10 NOV 2003, DOI: 10.1002/gps.1007

  14. Degradability of the linear azo polymer conjugated 5,5′-azodisalicylic acid segment in the main chain for colon-specific drug delivery

    Journal of Applied Polymer Science

    Volume 108, Issue 5, 5 June 2008, Pages: 3305–3312, Junying Lai, Kehua Tu, Hongjun Wang, Zhengjian Chen and Li-Qun Wang

    Version of Record online : 5 MAR 2008, DOI: 10.1002/app.27741

  15. Posters

    Bipolar Disorders

    Volume 7, Issue s2, June 2005, Pages: 27–117,

    Version of Record online : 2 JUN 2005, DOI: 10.1111/j.1399-5618.2005.00226.x

  16. Economic evaluations in bipolar disorder: a systematic review and critical appraisal

    Bipolar Disorders

    Volume 16, Issue 6, September 2014, Pages: 557–582, Anees Ahmed Abdul Pari, Judit Simon, Jane Wolstenholme, John R Geddes and Guy M Goodwin

    Version of Record online : 11 JUN 2014, DOI: 10.1111/bdi.12213

  17. Poster Absracts

    Bipolar Disorders

    Volume 6, Issue s1, February 2004, Pages: 25–41,

    Version of Record online : 19 DEC 2003, DOI: 10.1111/j.1398-5647.2004.079_5.x

  18. The development and validation of a method for quantifying olanzapine in human plasma by liquid chromatography tandem mass spectrometry and its application in a pharmacokinetic study

    Clinical and Experimental Pharmacology and Physiology

    Volume 42, Issue 3, March 2015, Pages: 305–313, Noely Camila Tavares Cavalcanti Bedor, Danilo César Galindo Bedor, Carlos Eduardo Miranda de Sousa, Felipe Nunes Bonifácio, Daniel da Mota Castelo Branco, Leila Bastos Leal and Davi Pereira de Santana

    Version of Record online : 11 FEB 2015, DOI: 10.1111/1440-1681.12353

  19. Pharmacokinetics of Olanzapine After Single-Dose Oral Administration of Standard Tablet Versus Normal and Sublingual Administration of an Orally Disintegrating Tablet in Normal Volunteers

    The Journal of Clinical Pharmacology

    Volume 46, Issue 2, February 2006, Pages: 164–171, Dr John S. Markowitz, Dr C. Lindsay DeVane, Dr Robert J. Malcolm, Ms Holly A. Gefroh, Dr Jun-Sheng Wang, Dr Hao-Jie Zhu and Dr Jennifer L. Donovan

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270005283839

  20. Effect of Antipsychotic Medications on Glucose and Lipid Levels

    The Journal of Clinical Pharmacology

    Volume 51, Issue 5, May 2011, Pages: 631–638, Dr Parminder S. Chaggar, Dr Steven M. Shaw and Dr Simon G. Williams

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270010368678